AzTrials
AzTrials

Periodontal DiseasesNCT04640506

Accuracy of Assessing the Gingival Biotype in Upper Anterior in Adult Patients, Using Different Methods.

An observational study of Periodontal Diseases, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study is a Diagnostic accuracy study that determining the accuracy of assessing the gingival biotype and some other anatomic parameters,including (crown width / crown length ratio, attached gingival width, labial bone thickness and papilla volume) by different methods :1- probe transparency, 2-transgingival… Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Periodontal Diseases
How many people
63 participants
Where
1 siteEgypt
Study dates
1 Nov 2020to Aug 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Adult Egyptian dental patients receiving esthetic rehabilitation treatment (implant placement, restorative treatments, periodontal therapy, and root cov¬erage) on anterior maxilla at faculty of Dentistry, Cairo University.

Who may be able to join

  • Male and female Patients whose age is between 18 to 40 years old.
  • Health teeth only will be included.
  • Patients who already need esthetic rehabilitation treatment (implant placement, restorative treatments, periodontal therapy, and root coverage) on anterior maxilla and this treatment needs to investigate the gingival biotype.
  • An un-inflamed periodontal condition with a periodontal probing depth of no more than 3 mm, a bleeding index of < 2, and no gingival recession on maxillary anterior teeth.
  • Provide informed consent.

Who cannot join

  • Pregnant or lactating females.
  • Restoration or crowns in the maxillary anterior dentition.
  • Malocclusion.
  • Use of any medication affecting the soft tissue.
  • Cigarette smoking.
  • Individuals with chronic systemic diseases such as diabetes, endocrine and haematological pathologies.
Show all 9Show fewer
  • Patients having problem in opening their mouth or undergoing inter-maxillary fixation where oral examination will not be possible.
  • Patients diagnosed with psychiatric problems or intoxicated with alcohol or drugs.
  • Patients with congenital disorders or craniofacial anomalies such as cleft lip and palate

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Fahd Ayad hammoodi Al-janabi

    Giza

    Fahd Ayad Al-janabi, Master, 00201144464491, Fahd.ayad92@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Accuracy of Assessing the Gingival Biotype in the Anterior Maxillary Area in Adult Patients, Using Different Measurement Methods.

The study is a Diagnostic accuracy study that determining the accuracy of assessing the gingival biotype and some other anatomic parameters,including (crown width / crown length ratio, attached gingival width, labial bone thickness and papilla volume) by different methods :1- probe transparency, 2-transgingival probing, 3-cone beam computed tomography, 4-intraoral digital scanning, 5-extraoral digital scanning

Read the detailed description
  • Patients will be recruited in periodontic department faculty of dentistry Cairo university.
  • Patients who already need esthetic rehabilitation treatment (implant placement, restorative treatments, periodontal therapy, and root coverage) on anterior maxilla and this treatment needs to investigate the gingival biotype.
  • Medical history will be taken.
  • Oral examination will be done.
  • Full mouth periodontal examination and charting will be done for each patient.
  • The investigation will be explained to the patient.
  • All the investigations will be carried out by one investigator.
  • Dental patients will be received to the clinic (for esthetic rehabilitation treatment such as implant placement, restorative treatments, periodontal therapy, and root coverage on anterior maxilla).
  • Patients who needs treatment will be investigated the gingival biotype by the five measurement methods (PT, TP, CBCT, IDS and EDS).
  • Patients refusing to participate will be reported with the cause of their refusal.
  • Conventional clinical examination will be held on a dental unit using the light of the unit, mirror and probe.
  • Before the investigation, the aim of the study will be explained to the patient and the patient's acceptance to participate in the survey will be obtained.
  • Periodontal status will be evaluated including assessment of gingival index (GI), plaque index (PI), probing pocket depth (PPD) on aesthetic zone in maxillary teeth by using UNC 15 periodontal probe which is 15mm long probe with markings at each millimetre and colour coded at 5th,10th and 15th mm.
  • Then an investigator will evaluate the gingival biotype by probing Transparency (PT) as reported by (Kan et al., 2010). The periodontal probe will be softly inserted into the gingival sulcus till it reaches the sound bone on the labial side of the maxil¬lary anterior teeth and it will be parallel to the long axis of the crown. The gingival biotype will be considered as thick if the probe tip is not seen into the tissue and it will be considered as thin if the probe was seen. If the thick en d of the probe was seen into the tissue but the thin end was not, then it will be considered as a moderate biotype.
  • The second method of assessment to the gingival biotype will be carried out using CBCT with lip retraction. It is important to note that the patients will not receive additional radiation exposure for the purpose of this investigation and to give us clear details about soft tissue, patients have already underwent CBCT examination as an investigation method for aesthetic rehabilitation treatment.
  • Afterwards, gingival biotype assessment will be done by intraoral digital examination (Kim et al., 2016). This is the third method; the investigation of gingival biotype of the anterior maxilla will be done by means of a three-dimensional intraoral scanner. The intraoral scanning data will be acquired in stereolithogra¬phy (STL) format and will be matched with the CBCT data. Three highly radiopaque and relatively fixed positions in the teeth will be chosen as fiducially markers to match the STL files with the CBCT images in accordance with a best-fit algorithm using TRIOS software (3Shape).
  • Finally, the fourth method for gingival biotype investigation will be performed by extraoral digital scanning (EDS) of a gypsum cast of the maxillary teeth, then the classic alginate impression of the max-illary arch and cast with dental stone will be made, gyp¬sum cast will be scanned using a three-dimen-sional scanner, and the STL data will be matched with the CBCT image according to a best-fit algorithm as in intraoral method.
  • Assessment of some anatomic parameters (crown width/crown length ratio, attached gingival width, labial bone thickness and papilla volume) will also be performed.
Medical subject headings
Periodontal Diseases

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. gingival biotype assessment by different methods.

    will be assess by different methods measurement

    1. probe transparency (PT)
    2. transgingival probing (TP) , 3-cone-beam computed tomography (CBCT)

    4-intraoral digital scanning (IDS) 5-extraoral digital scanning (EDS)

    I will be measured according to De Rouck et al. :

    • less than 1 mm thin-scalloped biotype'' (cluster A1): ''slender teeth, a narrow zone of keratinized tissue and a highly scalloped gingival margin
    • more than 1 mm 'thick-flat biotype'' (cluster B): A clear thick gingiva was found in about two-thirds quadratic teeth, a broad zone of keratinized tissue and a flat gingival margin
    • more than 1 mm (cluster A2): a clear thick gingiva with slender teeth, a narrow zone of keratinized tissue and a high gingival scallop

    Measured: the outcome measure will be assessed and for which data will be reported up to 24 weeks"

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Nov 2020
  2. Study start1 Nov 2020
  3. Primary completionJul 2021 (estimated)
  4. Study completionAug 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Other
Enrolment
63 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04640506
Sponsor's protocol ID
PER -3-3-1
Status last verified
Nov 2020
First submitted
25 Sep 2020
Last updated
24 Nov 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

gingival biotype assessment by different methods. (time frame: the outcome measure will be assessed and for which data will be reported up to 24 weeks"). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in